This document discusses neonatal infections including neonatal sepsis and ophthalmia neonatorum. It covers factors that make newborns susceptible to infection, modes of transmission from mother to newborn, classifications of neonatal infections, clinical signs and symptoms, management including treatment with antibiotics, and localized infections like umbilical cord infections and skin infections. It provides details on early onset sepsis within 3 days of life typically from maternal sources and late onset sepsis after 3 days often from hospital-acquired infections. Ophthalmia neonatorum refers to conjunctivitis in newborns with bacterial causes like gonorrhea and chlamydia requiring prompt treatment to prevent vision loss.
Ophthalmia Neonatorum or Neonatal ConjunctivitisAakanksha Bajpai
This presentation describe the condition of eye which is very common among neonates i.e. ophthalmia neonatorum which is otherwise also known as neonatal conjunctivitis. the major causes,diagnostic tests and manqgement is described here. Also ways to prevent it are explained.
BIRTH INJURIES IN NEWBORN: Definition of birth injuries , statistics, etiology, classification of birth injuries , head injuries: cephalhematoma and Caput succedaneum, skull fractures
, nerve injuries: erb's palsy and klumpke's palsy, bone injuries: clavicular and long bone fracture , intra-abdominal and soft tissue injuries, management and prevention of birth injuries
Ophthalmia Neonatorum or Neonatal ConjunctivitisAakanksha Bajpai
This presentation describe the condition of eye which is very common among neonates i.e. ophthalmia neonatorum which is otherwise also known as neonatal conjunctivitis. the major causes,diagnostic tests and manqgement is described here. Also ways to prevent it are explained.
BIRTH INJURIES IN NEWBORN: Definition of birth injuries , statistics, etiology, classification of birth injuries , head injuries: cephalhematoma and Caput succedaneum, skull fractures
, nerve injuries: erb's palsy and klumpke's palsy, bone injuries: clavicular and long bone fracture , intra-abdominal and soft tissue injuries, management and prevention of birth injuries
Postpartum psychosis is a severe mental illness which develops acutely in the early postnatal period. It is a psychiatric emergency. Identifying women at risk allows development of care plans to allow early detection and treatment. Management requires specialist care. Health professionals must take into account the needs of the family and new baby, as well as the risks of medication whilst breast-feeding.
Birth Injuries are the common complications of Instrumental Delivery. So intrapartum management should be done very carefully in ordered to ensure healthy and good outcome of baby.
Thermal care is central to reducing morbidity and mortality in newborns. Thermoregulation is the ability to balance heat production and heat loss in order to maintain body temperature within a certain normal range. The average “normal” axillary temperature is considered to be 37°C
Postpartum psychosis is a severe mental illness which develops acutely in the early postnatal period. It is a psychiatric emergency. Identifying women at risk allows development of care plans to allow early detection and treatment. Management requires specialist care. Health professionals must take into account the needs of the family and new baby, as well as the risks of medication whilst breast-feeding.
Birth Injuries are the common complications of Instrumental Delivery. So intrapartum management should be done very carefully in ordered to ensure healthy and good outcome of baby.
Thermal care is central to reducing morbidity and mortality in newborns. Thermoregulation is the ability to balance heat production and heat loss in order to maintain body temperature within a certain normal range. The average “normal” axillary temperature is considered to be 37°C
A Presentation I presented during my neonatology rotation during my internship in NICU out born UITH . Dedicated to all medical interns all over the world. Thanks to my supervising consultants
The legal implications of nursing practice are tied to licensure, state and federal laws, scope of practice and a public expectation that nurses practice at a high professional standard. The nurse's education, license and nursing standard provide the framework by which nurses are expected to practice.
Multiple pregnancy is used to describe the development of more than one fetus in the uterus at the same time. It is a high risk pregnancy. Careful supervision and proper monitoring is needed for prevention of further complications.
Pre-term, Small for gestational age and Post-term InfantLipi Mondal
Due to high risk of pregnancy there are several adverse outcome or poor perinatal outcome we can see.... So most commonly adverse out come should be known by health care providers.
Organization, Transportation, Setting and Management of Neonatal Intensive Ca...Lipi Mondal
Neonatal Intensive Care Unit is a specialized are where newborn care is to be given as per need of the babies where each and every aspect is important in neonate's heath care management.
Placenta Previa is one type of Antepartum Hemorrhage and an obstetrical emergency too... So in health care management having knowledge regarding this topic is very important in Obstetrics.
Medical Technology Tackles New Health Care Demand - Research Report - March 2...pchutichetpong
M Capital Group (“MCG”) predicts that with, against, despite, and even without the global pandemic, the medical technology (MedTech) industry shows signs of continuous healthy growth, driven by smaller, faster, and cheaper devices, growing demand for home-based applications, technological innovation, strategic acquisitions, investments, and SPAC listings. MCG predicts that this should reflects itself in annual growth of over 6%, well beyond 2028.
According to Chris Mouchabhani, Managing Partner at M Capital Group, “Despite all economic scenarios that one may consider, beyond overall economic shocks, medical technology should remain one of the most promising and robust sectors over the short to medium term and well beyond 2028.”
There is a movement towards home-based care for the elderly, next generation scanning and MRI devices, wearable technology, artificial intelligence incorporation, and online connectivity. Experts also see a focus on predictive, preventive, personalized, participatory, and precision medicine, with rising levels of integration of home care and technological innovation.
The average cost of treatment has been rising across the board, creating additional financial burdens to governments, healthcare providers and insurance companies. According to MCG, cost-per-inpatient-stay in the United States alone rose on average annually by over 13% between 2014 to 2021, leading MedTech to focus research efforts on optimized medical equipment at lower price points, whilst emphasizing portability and ease of use. Namely, 46% of the 1,008 medical technology companies in the 2021 MedTech Innovator (“MTI”) database are focusing on prevention, wellness, detection, or diagnosis, signaling a clear push for preventive care to also tackle costs.
In addition, there has also been a lasting impact on consumer and medical demand for home care, supported by the pandemic. Lockdowns, closure of care facilities, and healthcare systems subjected to capacity pressure, accelerated demand away from traditional inpatient care. Now, outpatient care solutions are driving industry production, with nearly 70% of recent diagnostics start-up companies producing products in areas such as ambulatory clinics, at-home care, and self-administered diagnostics.
Global launch of the Healthy Ageing and Prevention Index 2nd wave – alongside...ILC- UK
The Healthy Ageing and Prevention Index is an online tool created by ILC that ranks countries on six metrics including, life span, health span, work span, income, environmental performance, and happiness. The Index helps us understand how well countries have adapted to longevity and inform decision makers on what must be done to maximise the economic benefits that comes with living well for longer.
Alongside the 77th World Health Assembly in Geneva on 28 May 2024, we launched the second version of our Index, allowing us to track progress and give new insights into what needs to be done to keep populations healthier for longer.
The speakers included:
Professor Orazio Schillaci, Minister of Health, Italy
Dr Hans Groth, Chairman of the Board, World Demographic & Ageing Forum
Professor Ilona Kickbusch, Founder and Chair, Global Health Centre, Geneva Graduate Institute and co-chair, World Health Summit Council
Dr Natasha Azzopardi Muscat, Director, Country Health Policies and Systems Division, World Health Organisation EURO
Dr Marta Lomazzi, Executive Manager, World Federation of Public Health Associations
Dr Shyam Bishen, Head, Centre for Health and Healthcare and Member of the Executive Committee, World Economic Forum
Dr Karin Tegmark Wisell, Director General, Public Health Agency of Sweden
India Clinical Trials Market: Industry Size and Growth Trends [2030] Analyzed...Kumar Satyam
According to TechSci Research report, "India Clinical Trials Market- By Region, Competition, Forecast & Opportunities, 2030F," the India Clinical Trials Market was valued at USD 2.05 billion in 2024 and is projected to grow at a compound annual growth rate (CAGR) of 8.64% through 2030. The market is driven by a variety of factors, making India an attractive destination for pharmaceutical companies and researchers. India's vast and diverse patient population, cost-effective operational environment, and a large pool of skilled medical professionals contribute significantly to the market's growth. Additionally, increasing government support in streamlining regulations and the growing prevalence of lifestyle diseases further propel the clinical trials market.
Growing Prevalence of Lifestyle Diseases
The rising incidence of lifestyle diseases such as diabetes, cardiovascular diseases, and cancer is a major trend driving the clinical trials market in India. These conditions necessitate the development and testing of new treatment methods, creating a robust demand for clinical trials. The increasing burden of these diseases highlights the need for innovative therapies and underscores the importance of India as a key player in global clinical research.
Antibiotic Stewardship by Anushri Srivastava.pptxAnushriSrivastav
Stewardship is the act of taking good care of something.
Antimicrobial stewardship is a coordinated program that promotes the appropriate use of antimicrobials (including antibiotics), improves patient outcomes, reduces microbial resistance, and decreases the spread of infections caused by multidrug-resistant organisms.
WHO launched the Global Antimicrobial Resistance and Use Surveillance System (GLASS) in 2015 to fill knowledge gaps and inform strategies at all levels.
ACCORDING TO apic.org,
Antimicrobial stewardship is a coordinated program that promotes the appropriate use of antimicrobials (including antibiotics), improves patient outcomes, reduces microbial resistance, and decreases the spread of infections caused by multidrug-resistant organisms.
ACCORDING TO pewtrusts.org,
Antibiotic stewardship refers to efforts in doctors’ offices, hospitals, long term care facilities, and other health care settings to ensure that antibiotics are used only when necessary and appropriate
According to WHO,
Antimicrobial stewardship is a systematic approach to educate and support health care professionals to follow evidence-based guidelines for prescribing and administering antimicrobials
In 1996, John McGowan and Dale Gerding first applied the term antimicrobial stewardship, where they suggested a causal association between antimicrobial agent use and resistance. They also focused on the urgency of large-scale controlled trials of antimicrobial-use regulation employing sophisticated epidemiologic methods, molecular typing, and precise resistance mechanism analysis.
Antimicrobial Stewardship(AMS) refers to the optimal selection, dosing, and duration of antimicrobial treatment resulting in the best clinical outcome with minimal side effects to the patients and minimal impact on subsequent resistance.
According to the 2019 report, in the US, more than 2.8 million antibiotic-resistant infections occur each year, and more than 35000 people die. In addition to this, it also mentioned that 223,900 cases of Clostridoides difficile occurred in 2017, of which 12800 people died. The report did not include viruses or parasites
VISION
Being proactive
Supporting optimal animal and human health
Exploring ways to reduce overall use of antimicrobials
Using the drugs that prevent and treat disease by killing microscopic organisms in a responsible way
GOAL
to prevent the generation and spread of antimicrobial resistance (AMR). Doing so will preserve the effectiveness of these drugs in animals and humans for years to come.
being to preserve human and animal health and the effectiveness of antimicrobial medications.
to implement a multidisciplinary approach in assembling a stewardship team to include an infectious disease physician, a clinical pharmacist with infectious diseases training, infection preventionist, and a close collaboration with the staff in the clinical microbiology laboratory
to prevent antimicrobial overuse, misuse and abuse.
to minimize the developme
Navigating Challenges: Mental Health, Legislation, and the Prison System in B...Guillermo Rivera
This conference will delve into the intricate intersections between mental health, legal frameworks, and the prison system in Bolivia. It aims to provide a comprehensive overview of the current challenges faced by mental health professionals working within the legislative and correctional landscapes. Topics of discussion will include the prevalence and impact of mental health issues among the incarcerated population, the effectiveness of existing mental health policies and legislation, and potential reforms to enhance the mental health support system within prisons.
Explore our infographic on 'Essential Metrics for Palliative Care Management' which highlights key performance indicators crucial for enhancing the quality and efficiency of palliative care services.
This visual guide breaks down important metrics across four categories: Patient-Centered Metrics, Care Efficiency Metrics, Quality of Life Metrics, and Staff Metrics. Each section is designed to help healthcare professionals monitor and improve care delivery for patients facing serious illnesses. Understand how to implement these metrics in your palliative care practices for better outcomes and higher satisfaction levels.
R3 Stem Cells and Kidney Repair A New Horizon in Nephrology.pptxR3 Stem Cell
R3 Stem Cells and Kidney Repair: A New Horizon in Nephrology" explores groundbreaking advancements in the use of R3 stem cells for kidney disease treatment. This insightful piece delves into the potential of these cells to regenerate damaged kidney tissue, offering new hope for patients and reshaping the future of nephrology.
2. FACTORS SPECIFIC TO NEONATAL
INFECTIONS
• Diverse modes of transmission of infectious agents from mother to fetus
or newborns during prenatal, or natal or postnatal period.
• Newborns may be less capable of responding to infections because of
one or more of immunologic deficiencies.
• Co-existing conditions often complicate the diagnosis and treatment of
neonatal infections like RDS, congenital pneumonia ,CHD.
3. CONTD…
• The extremely variable clinical manifestations of infectious diseases of
newborns that may present as mild or severe manifestation of focal or
systemic infections.
• The maternal infection is often undiagnosed during pregnancy as the
mother is asymptomatic or non specific signs and symptom during acute
infection.
• The wide variety of etiologic agents that infect newborns like bacteria, virus,
etc.
• The immature LBWN remain in the hospital for long period that put them at
continuous risk of nosocomial infection.
4. PORTALS OF ENTRY OF NEONATAL
INFECTIONS:
1. INTRA-UTERINE (TRANS-PLACENTAL):
a. MATERNAL BLOOD STREAM
b. ASCENDING INFECTION DUE PROLONGED RUPTURE OF MEMBRANES
C. PROLONGED LABOR AND REPEATED PV EXAM.
2. DURING PASSAGE OF THE NEONATE THROUGH INFECTED BIRTH CANAL:
3. POSTNATALLY ACQUIRED (NOSOCOMIAL):
• VIRAL INFECTIONS
• CONGENITAL
• PERINATAL
• BACTERIAL INFECTIONS
5. MODE OF INFECTION
• ANTENATAL PERIOD:
Antenatal infections may occur due to various micro-organisms & described with an
acronym of STORCH where in:
• S- SYPHILIS
• T- TOXOPLASMOSIS
• O- OTHER(GONOCOCCI INFECTIONS, TUBERCULAR INFECTIONS, MALARIA,
VARICELLA, HEPATITIS B, HIV)
• R- RUBELLA
• C- CYTOMEGALO VIRUS
• H- HERPES SIMPLEX VIRUS
6. • INTRA-NATAL PERIOD:
• Group B streptococcus is the most common (bedford-russell & plumb, 2006)
• 60% is early onset
• 20% fatal (when there is septicemia)
• Other types –listeria and herpes
• Aspiration of infected liquor in prolonged labor following early rupture of membrane
which may lead to neonatal aspiration pneumonia.
• Infection may occur due to related vaginal examination by the delivery assistant
especially when the membrane is ruptured.
• Infected birth passage may infect eyes & mouth of the neonate leading to opthalmia
neonatrum & oral thrush.
• Improper aseptic technique during care of umbilical cord may cause umbilical sepsis.
7. POSTNATAL PERIOD:
• Transmission of infection from human contact or care-givers especially
from infected hands of mother or family members & health care
providers.
• Cross infection from other baby who is infected & no barrier nursing is
practiced & universal precautions are not followed.
• Infected articles for baby care & contaminated clothing
• Invasive procedures without aseptic technique
• Infected environment around neonates at hospital or home.
8. CLASSIFICATION OF NEONATAL INFECTIONS
INTRA-UTERINE
INFECTIONS
PERINATAL
INFECTIONS
EARLY
NEONATAL
INFECTIONS
LATE NEONATAL
INFECTIONS
POSTNATAL
INFECTIONS
11. CONTD…
• CARDIOVASCULAR
• HYPOTENSION
• METABOLIC ACIDOSIS
• TACHYCARDIA
• TEMPERATURE INSTABILITY
• NEWBORN TEMPERATURE <36 OR PYREXIAL
• GASTROINTESTINAL
• VOMITING, DIARRHOEA, ABDOMINAL DISTENSION, POOR FEEDING
12. CONTD…
• NEUROLOGICAL
• ACTIVITY DECREASED OR LETHARGY, IRRITABILITY
• TREMOR OR SEIZURE, HYPOREFLEXIA OR HYPOTONIA
• HIGH PITCHED CRY, FONTANELLE FULL
• SKIN
• PALLOR OR SKIN MOTTLING
• PETECHIAE OR PURPURA
• COLD OR CLAMMY SKIN
• CYANOSIS
• JAUNDICE
13. MANAGEMENT
• Observe for signs and risks
• ‘Universal precautions’-prevention
• Minimise risk of infection
• Septic screen if infection suspected – full or partial
• Treat with antibiotics if required based on cultures
• The baby should be isolated to prevent cross infection.
14. LOCALIZED INFECTIONS
• An infections is a certain part of the baby’s body(cord,skin,eye,mouth)
• Can spread quickly through the newborn’s small body & causes sepsis.
• Quick & correct treatment of localized infections may prevent sepsis & possible
deaths.
• UMBILICAL CORD INFECTION
• Infection around the umbilical cord.
• Can easily pass through the cord- sepsis or death if treatment delayed
• Treatment- wash the cord & stump & apply gentian violet 0.5%, ampicillin &
gentamycin.
15. CONTD…
• SKIN INFECTION
• Skin pastules
• Localized or serious skin infection
• Wash the skin & apply gentian violet 0.5%, serious infection- Cloxacillin 50 mg/kg IM
• EYE INFECTION
• Bacteria- Chlamydia
• Treatment- Ceftriaxone 50 mg/kg
• ORAL THRUSH
• White patches on the mucus membrane or tongue
• Treatment- nystatin 1,00,000 U/ml- 1 to 2 ml in baby’s mouth 4 times a day, gentian
violet.
16. NEONATAL SEPSIS
• DEFINITION
• Neonatal sepsis is a clinical syndrome characterized by signs and symptoms of
infection with or without accompanying bacteremia in the first month of life. It
encompasses various systemic infections of the newborn such as septicemia,
meningitis, pneumonia, arthritis, osteomyelitis, and urinary tract infections.
• Superficial infections like conjunctivitis and oral thrush are not usually included
under neonatal sepsis.
17. CLASSIFICATION
• Early onset sepsis (EOS):
• It presents within the first 72 hours of life. In severe cases, the neonate may be
symptomatic at birth. Infants with EOS usually present with respiratory distress and
pneumonia. The source of infection is generally the maternal genital tract. Some
maternal/ perinatal conditions have been associated with an increased risk of EOS.
Knowledge about these potential risk factors would help in early diagnosis of sepsis.
• 1. Low birth weight (<2500 grams) or prematurity
• 2. Febrile illness in the mother with evidence of bacterial infection within 2 weeks prior
to delivery
18. CONTD…
• 3. Foul smelling and/or meconium stained liquor
• 4. Rupture of membranes >24 hours
• 5. Single unclean or > 3 sterile vaginal examination(s) during labor
• 6. Prolonged labor (sum of 1st and 2nd stage of labor > 24 hrs)
• 7. Perinatal asphyxia (APGAR score <4 at 1 minute) presence of foul smelling liquor or
three of the above mentioned risk factors warrant initiation of antibiotic treatment.
Infants with two risk factors should be investigated and then treated accordingly.
19. LATE ONSET SEPSIS (LOS):
• It usually presents after 72 hours of age. The source of infection in LOS is either
nosocomial (hospital-acquired) or community-acquired and neonates usually
present with septicemia, pneumonia or meningitis. Various factors that predispose
to an increased risk of nosocomial sepsis include low birth weight, prematurity,
admission in intensive care unit, mechanical ventilation, invasive procedures,
administration of parenteral fluids, and use of stock solutions.
• Factors that might increase the risk of community-acquired LOS include poor
hygiene, poor cord care, bottle-feeding, and pre-lacteal feeds. In contrast,
breastfeeding helps in prevention of infections.
20. CLINICAL FEATURES
• NON-SPECIFIC FEATURES:
• The earliest signs of sepsis are often subtle and nonspecific; indeed, a high index of
suspicion is needed for early diagnosis. Neonates with sepsis may present with one or
more of the following symptoms and signs:
• (a) Hypothermia or fever (former is more common in preterm low birth weight infants)
• (b) Lethargy, poor cry, refusal to suck
• (c) Poor perfusion, prolonged capillary refill time
• (d) Hypotonia, absent neonatal reflexes
• (e) Brady/tachycardia
• (f) Respiratory distress, apnea and gasping respiration
• (g) Hypo/hyperglycemia
21. CONTD…
• SPECIFIC FEATURES RELATED TO VARIOUS SYSTEMS:
• CENTRAL NERVOUS SYSTEM (CNS):
• Bulging Anterior Fontanelle, Vacant Stare, High-pitched Cry, Excess Irritability, Stupor/Coma,
Seizures, Neck Retraction.
• CARDIAC: Hypotension, Poor Perfusion, Shock
• GASTROINTESTINAL:
• Feed Intolerance, Vomiting, Diarrhea, Abdominal Distension, Paralytic Ileus, Necrotizing
Enterocolitis
• HEPATIC: Hepatomegaly, Direct Hyperbilirubinemia (Especially With Urinary Tract Infections)
• RENAL: Acute Renal Failure
• HEMATOLOGICAL: Bleeding, Petechiae, Purpura
• SKIN CHANGES: Multiple Pustules, Abscess, Mottling, Umbilical Redness And Discharge.
22. MANAGEMENT
• INDICATIONS FOR STARTING ANTIBIOTICS:
• The indications for starting antibiotics in neonates at risk of EOS include any one of
the following:
• (a) presence of >3 risk factors for early onset sepsis
• (b) presence of foul smelling liquor
• (c) presence of 2 antenatal risk factor(s) and a positive septic screen and strong
clinical suspicion of sepsis.
• THE INDICATIONS FOR STARTING ANTIBIOTICS IN LOS INCLUDE:
• (A) positive septic screen and/or (b) strong clinical suspicion of sepsis.
23. CONTD…
• PROPHYLACTIC ANTIBIOTICS:
• Do not use prophylactic antibiotics in the following circumstances: infants on IV fluids/TPN,
meconium aspiration syndrome, and after exchange transfusion(s). An exchange transfusion
conducted under strict asepsis (single use catheter, sterile gloves, removal of catheter after the
procedure) does not increase the risk of sepsis and hence does not merit antibiotics. However a
messy exchange transfusion could be treated with prophylactic antibiotics. In our unit, ventilated
neonates are treated with prophylactic amikacin for the period of ventilation.
• For infections that are acquired during hospital stay, resistant pathogens are likely and a
combination of ampicillin or cloxacillin with gentamicin or amikacin may be instituted. In
presence of multiple resistant strains of klebsiella and other gram-negative bacilli, a combination
of a third generation cephalosporin (cefotaxime or ceftazidime) with amikacin may be
appropriate.
• A combination of piperacillin-tazobactam with amikacin should be considered if pseudomonas
sepsis is suspected. Penicillin resistant staphylococcus aureus should be treated with cloxacillin,
nafcillin or methicillin.
24. CONTD…
• ADJUVANT THERAPY:
• EXCHANGE TRANSFUSION (ET):
• Sadana et al17 have evaluated the role of double volume exchange transfusion in septic
neonates with sclerema and demonstrated a 50% reduction in sepsis related mortality in
the treated group. We perform double-volume exchange transfusion with crossmatched
fresh whole blood as adjunctive therapy in septic neonates with sclerema.
• INTRAVENOUS IMMUNOGLOBULIN (IVIG):
• Non-specific pooled IVIG has not been found to be useful.
25. OPTHALMIA NEONATRUM
• INTRODUCTION
• Ophthalmia neonatorum refers to any conjunctivitis occurring in the first 28 days of life.
It is most commonly infective in origin: bacterial causes include chlamydia trachomatis,
neisseria gonorrhoeae, staphylococcus aureus, streptococcus pneumoniae and various
other organisms. Less often there can be viral causes - notably the herpes simplex virus.
It may also occur as a reaction to chemical irritants, and is a self-limiting condition
lasting no more than 24 to 36 hours but infections need treatment.
• In most cases ophthalmia neonatorum is a mild illness. The exception is that due to
gonococcal infection, which can progress rapidly to corneal damage and permanent
visual impairment.This may also cause systemic complications.
26. TYPES
• CHEMICAL CONJUNCTIVITIS
• There is a mild irritation, tearing and redness in a baby who has been administered
prophylactic silver nitrate (used for the prevention of gonorrhoeal infection) within the
preceding 24-48 hours.
• BACTERIAL CONJUNCTIVITIS
• This usually (but not invariably) has a longer incubation period than for the other
infective causes, presenting with a subacute onset between the 4th and 28th day of
life. Depending on the pathogen, there may be a mixed picture of a red eye with lid
swelling and a varying amount of purulent discharge. Specific common types of
bacterial infection are:
• GONORRHOEAL INFECTION - Typically, 1-5 days after birth but it may occur later:
hyperacute conjunctival injection and chemosis, lid oedema and severe purulent
discharge. There may be associated corneal ulceration and perforation.
27. CONTD…
• CHLAMYDIAL INFECTION - 5-14 days after birth (some report up to 28 days after
birth): unilateral/bilateral watery discharge which becomes copious and purulent later
on. There may be associated pre-septal cellulitis and, less commonly, rhinitis, otitis and
pneumonitis. The eyes are usually less inflamed than in the case of gonococcal
infection.
• VIRAL CONJUNCTIVITIS
• Onset is acute, 1-14 days after birth: unilateral/bilateral sero-sanguinous discharge ±
vesicular skin lesions. Other ocular features may include keratitis, anterior uveitis,
cataract, retinitis and (rarely) optic neuritis. Uncommonly, systemic infection can cause
jaundice, hepatosplenomegaly, pneumonitis, meningoencephalitis and disseminated
intravascular coagulation.
28. DIFFERENTIAL DIAGNOSIS
• A blocked nasolacrimal duct is common and results in a thick (sometimes
copious) discharge which may be sticky or crusty. The eye is not red and the
baby is otherwise well. The discharge may be intermittent and responds well
to simple cleansing. Most babies' ducts clear as they grow, the majority
functioning normally by 12 months of age.
29. MANAGEMENT
• REFERRAL
• The majority of neonates presenting with a sticky discharge have a benign cause - most
frequently due to blocked nasolacrimal duct(s). Features suggesting that referral is
necessary are those suggestive of gonococcal involvement, and include:
• Conjunctival redness, especially if the bulbar conjunctiva (overlying the sclera) is
involved. If the onset is sudden and severe. If the baby is distressed or unwell. If both
eyes are affected. If maternal gonococcal infection is suspected. If the mother is
concerned, or you are concerned.
• If you suspect gonococcal infection, refer immediately. Early and appropriate treatment
have long been recognised as the key to preventing consequent blindness.
30. CONTD…
• INITIAL THERAPY
• Prior to results from gram staining (or if these are inconclusive), it is appropriate to
start the infant on a broad-spectrum antibiotic - eg, ofloxacin 0.3% QDS for a week, or
until the microbiological results have come back.
• If the initial infection recurs, chlamydia should be reconsidered (even if the baby first
tested negative), as this organism is difficult to demonstrate in the laboratory and can
be missed.
• Chemical conjunctivitis: no treatment is required.These babies need early review (24
hours) to confirm that this was indeed a case of chemical irritation as opposed to early
infection.
• Bacterial infection : treatment should be guided by the organism grown. If there is
corneal involvement, the baby may be hospitalised and treated as for microbial
keratitis.
31. CONTD…
• Chlamydial infection: oral erythromycin syrup (50 mg/kg/day in
four divided doses) for 14 days. Topical treatment alone is not
sufficient (and is not usually felt to be necessary when systemic
treatment is taken). The presence of chlamydia in the eyes
invariably indicates its presence in the respiratory tract too, which
is a further reason for systemic therapy.
32. CONTD…
• The mother and her sexual partner(s) will also need treating Gonorrhoeal infection.
These babies need hospitalisation and evaluation for disseminated disease.
• Hourly saline lavage is recommended to remove the discharge (qds). Additionally,
these infants can be treated with bacitracin eye ointment 2- to 4-hourly (topical
penicillins are unreliable due to resistance). If penicillin sensitivity is established then
penicillin drops are also used.
• There is no established treatment protocol but options include ceftriaxone (single
dose: 25-50 mg/kg intravenously (IV) or intramuscularly (IM), no more than 125 mg in
total) or cefotaxime (single dose: 100 mg/kg IV or IM).
• Topical atropine is used for corneal involvement.
33. CONTD…
• VIRAL INFECTION : These babies should be hospitalised and treated with IV aciclovir
(full-term infants: 45-60 mg/kg/day in three doses. This is continued for 14 days if there
is limited disease and 21 days if there is disseminated disease, which can be devastating)
in addition to topical antiviral preparations. Complications the complications mainly
relate to gonococcal conjunctivitis. Most other causes of conjunctivitis in the newborn
are fairly benign.
• GONOCOCCAL COMPLICATIONS INCLUDE:
• Keratitis. Conjunctival scarring. Superior corneal pannus.
• SIDE-EFFECTS OF TREATMENT (RARELY), Such as the association between oral
erythromycin and infantile hypertrophic pyloric stenosis (IHPS) reported in infants aged
<6 weeks, permanent visual impairment.
34. PROGNOSIS
• CHLAMYDIAL INFECTION: Good - 80% fully recover after one course of
treatment.
• BACTERIAL INFECTION: Rarely fails to respond to appropriate treatment.
• VIRAL INFECTION: The ocular prognosis can be poor and the systemic
sequelae may be fatal.
• CHEMICAL IRRITATION: Good - full spontaneous recovery expected after
24-36 hours.
35. NURSING MANAGEMENT
• All infants should receive ocular prophylaxis at birth to prevent gonococcal opthalmia.
Neonates presenting with signs of conjunctivitis should have conjunctival swab to be
sent.
• Infants should be followed during their treatment & upon completion of therapy to
ensure resolution of symptoms. For cases in which sexually transmitted bacteria are
implicated, the mothers & their sexual partners should be treated.
• Five clean practices should be followed during delivery- clean hands, clean tie, clean
blade, clean cord stump. Another important aspect is clean clothing for mother & baby.
• Hand washing before & after handling of the babies.
• Maintenance of cleanliness of the environment – delivery room, neonatal care unit,
postnatal area etc.
36. JOURNAL ARTICLE
• “RISK FACTORS FOR NEONATAL SEPSIS IN PUBLIC HOSPITALS OF MEKELLE CITY,
NORTH ETHIOPIA, 2015:UNMATCHED CASE CONTROL STUDY”
-DESTAALEM GEBREMEDHIN ,HAFTUBERHE
• OBJECTIVES
• Neonatal sepsis is a leading cause of neonatal morbidity and mortality, particularly in
the developing countries. Delays in the identification and treatment of neonatal sepsis
are among the main contributors to the high mortality. The aim of this study was to
determine the risk factors of neonatal sepsis in public hospitals of mekelle
city,tigrayregion,north ethiopia,2015.
37. CONTD…
• METHODS
• A hospital based case control study was done in public hospitals of mekelle city,
tigray region. Cases were neonates who had sepsis with their index mothers and
controls were neonates who hadn’t had sepsis with their index mothers.
Hematologic findings were used to diagnose sepsis once the neonates were being
clinically suspected. Cases and controls were selected using the systematic
sampling technique. Data were entered using epi info version 7 and the analyze
SPSS window20.The binary logistic regression model was used to test the
association between dependent an independent variables and multivariable
logistic regression was used to identify the associated risk factors to neonatal
sepsis.
38. CONTD..
• FINDINGS
• A total of 78 cases and 156 controls were included in this study. More than three
quarters (76.8%)of cases had early onset sepsis. The multivariable logistic regression
analysis showed that the possible risk factors of neonatal sepsis in this study were;
history of maternal urinary tract infection or sexually transmitted infection
[AOR=5.23;95% CI (1.82, 15.04)], prolonged rupture of membrane [AOR=7.43;95% CI
(2.04,27.1)], place of delivery; health center delivery[AOR=5.7;95% CI(1.71,19.03)],
intrapartum fever[AOR=6.1 95% CI(1.29,28.31)], APGAR score<7 at 5th
minute[AOR=68.9;95% CI(3.63,1308)] and not crying immediately at
birth[AOR=124.0;95% CI(6.5,2379)].